Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.28p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 5,319,314
  • Market Cap: £5.91m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Huw Jones 3,184,793 £8,758
Toni Hänninen 1,000,000 £2,750

Major Shareholders

Notifier** Holding Value*
Northern Standard Limited 422,727,272 £1,162,500
TRACARTA LIMITED 422,727,272 £1,162,500
First Equity Limited 179,000,000 £492,250
T and I Limited 160,000,000 £440,000
Oberon Investments Limited 80,475,000 £221,306
Spreadex Ltd 80,009,545 £220,026
Andrew Leach 80,000,000 £220,000
Simon Gibeon 71,400,000 £196,350
Rathbones Investment Management Ltd 25,789,246 £70,920
Sarum Investment SICAV Plc 25,700,000 £70,675
Octopus Investments Nominees Limited 21,875,000 £60,156
Octopus Investments Nominees Limited 21,875,000 £60,156
Vulpes Investment Management Pte Ltd 20,554,191 £56,524
InterTrader Limited 16,560,033 £45,540
Seneca Partners Limited 16,301,456 £44,829
North West Fund (Biomedical) LP 16,186,446 £44,513
Richard Griffiths and family 14,408,000 £39,622
AXA Framlington Investment Management Limited 13,399,724 £36,849
Chelverton Asset Management 12,500,000 £34,375
RAB Capital 8,750,000 £24,062
David and Monique Newlands 8,314,815 £22,866
Newlands Capital 8,314,815 £22,866
Ali Mortazavi 3,400,000 £9,350
PARTNERS INVESTMENT COMPANY LLP 3,114,089 £8,564
Letzone Limited 2,664,000 £7,326
Beaufort Securities Limited 2,457,568 £6,758
South Yorkshire Investment Capital Fund LP 1,394,550 £3,835

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.28p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 5,319,314
Shares Issued 2,148.96m
Market Cap £5.91m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.02% below the market average46.02% below the market average46.02% below the market average46.02% below the market average46.02% below the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Price Trend
92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average92.83% below the market average
82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average82.61% below the sector average
Income Not Available
Growth
15.76% below the market average15.76% below the market average15.76% below the market average15.76% below the market average15.76% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average

Theracryf Dividends

No dividends found

Trades for 02-Jun-2025

Time Volume / Share Price
16:16 5,106,454 @ 0.29p
08:29 212,860 @ 0.25p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page